Skip directly to content


Tygacil® is a tetracycline derivative (a glycylcycline) for intravenous infusion1. To date there has been no cross-resistance observed between Tygacil® and other antibacterials. Tygacil® is not affected by the major tetracycline-resistance mechanisms1


  1. Tygacil® (tigecycline) Prescribing Information. Pfizer Corporation Hong Kong Limited: Version January 2017.
[PP-CPF-HKG-0063] SEP 2019